CBWTF (Auxly Cannabis Group) Research & Development: $0.2 Mil (TTM As of Mar. 2026)


CBWTF Auxly Cannabis Group Inc CBWTF
36 GF Score
Price $0.12
GF Value $0.03
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Auxly Cannabis Group Research & Development?

Auxly Cannabis Group CBWTF -3.85% 36 Research & Development is $0.2 Mil as of Mar. 2026. GuruFocus rates CBWTF with a GF Score™ of 36/100 and a GF Value™ of $0.03 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Auxly Cannabis Group's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.2 Mil.

Auxly Cannabis Group  (OTCPK:CBWTF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Auxly Cannabis Group Research & Development Related Terms

Auxly Cannabis Group Research & Development Historical Data

* Premium members only.

The historical data trend for Auxly Cannabis Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Auxly Cannabis Group Research & Development Chart

Auxly Cannabis Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.22 0.37 0.00 0.00

Auxly Cannabis Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.07 0.12 0.00 0.03
CBWTF
36GF Score
Auxly Cannabis Group Inc CBWTF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Auxly Cannabis Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.2 Mil mean?
Auxly Cannabis Group (CBWTF) has a Research & Development of $0.2 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Auxly Cannabis Group and its competitors.
Is Auxly Cannabis Group's Research & Development too high?
Auxly Cannabis Group's current Research & Development is $0.2 Mil. Overall, Auxly Cannabis Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Auxly Cannabis Group's Research & Development compare to ZTS and UTHR?
Auxly Cannabis Group's Research & Development of $0.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Auxly Cannabis Group and its competitors. Auxly Cannabis Group's current Research & Development is $0.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Auxly Cannabis Group stock overvalued right now?
Based on GuruFocus' analysis, Auxly Cannabis Group (CBWTF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.03, compared to a current price of $0.12 — trading 308% above its estimated fair value. The current Research & Development is $0.2 Mil. Auxly Cannabis Group's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Auxly Cannabis Group (CBWTF), the current Research & Development is $0.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Auxly Cannabis Group (CBWTF) Overvalued in 2026?

Based on GuruFocus' analysis, Auxly Cannabis Group stock appears to be overvalued. The current stock price of $0.12 is trading 308% above its estimated GF Value™ of $0.03. GuruFocus considers Auxly Cannabis Group to be Significantly Overvalued.

Key valuation signals for CBWTF:

  • Research & Development: $0.2 Mil
  • GF Value™: $0.03 vs. price of $0.12 (308% above fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the CBWTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Auxly Cannabis Group Business Description

Other Exchanges 3KF:GermanyXLY:Canada
Address 777 Richmond Street West, Unit 002, Toronto, ON, CAN, M6J 0C2
Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company has created a portfolio of brands designed for a broad market of cannabis consumers, with differentiation in price points across targeted consumer segments. Its product portfolio comprises dried cannabis, fresh cannabis, cannabis plants, cannabis seeds, cannabis oil, edible cannabis, cannabis extracts, and cannabis topicals, among others, which are marketed through brands like Parcel, Black Forty, Foray, Dosecann, and Kolab Project.
36GF Score

Get the complete analysis for CBWTF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price
$0.03
GF Value